Skip to main content
Clinical Trials/NCT00816179
NCT00816179
Terminated
Not Applicable

Human Clinical Trial of Diagnostic Transgastric Endoscopic Peritoneoscopy for Staging of Pancreatic Head Mass

Jeffrey Hazey1 site in 1 country11 target enrollmentJuly 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Head Mass
Sponsor
Jeffrey Hazey
Enrollment
11
Locations
1
Primary Endpoint
Endoscopically visualize the abdominal cavity to determine absence or presence of metastatic lesions to successfully stage pancreatic head malignancies and direct surgical treatment.
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

This study is being done to find out if an endoscope passed down the throat, through the stomach, and into the abdomen can quickly and accurately examine the organs and tissue of the abdomen and take biopsies if needed.

Detailed Description

This study is being done to find out if an endoscope (a small, flexible tube with a camera mounted on the end) passed down the throat, through the stomach, and into the abdomen can quickly and accurately examine the organs and tissue of the abdomen and take biopsies if needed. We wish to determine if this endoscopic route is as fast and efficient as the laparoscopic route, which is the current standard of care.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
August 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Jeffrey Hazey
Responsible Party
Sponsor Investigator
Principal Investigator

Jeffrey Hazey

Associate Professor

Ohio State University

Eligibility Criteria

Inclusion Criteria

  • Age range 18-80
  • Radiographic diagnosis of resectable pancreatic head mass presumed to be pancreatic adenocarcinoma

Exclusion Criteria

  • Inability to obtain informed consent
  • Pregnancy
  • Intra-abdominal adhesions that preclude endoscopy
  • Contraindication to upper endoscopy such as stricture, stenosis of the foregut
  • Previous gastric surgery
  • Diagnosis of pancreatic body or tail tumor
  • History or current diagnosis of gastric ulcer
  • Metastatic disease diagnosed by CT, EUS, MRI, or nuclear imaging
  • Patient is not a candidate for resection based upon CT, EUS, MRI, or nuclear imaging
  • Antiplatelet medication not stopped at least 7 days prior to procedure

Outcomes

Primary Outcomes

Endoscopically visualize the abdominal cavity to determine absence or presence of metastatic lesions to successfully stage pancreatic head malignancies and direct surgical treatment.

Time Frame: Intraoperatively

Secondary Outcomes

  • Comparison of laparoscopic exploration (retrospectively) to endoscopic exploration.(1 year)
  • Ability to obtain peritoneal biopsies when appropriate during transgastric endoscopic procedures.(Intraoperatively)

Study Sites (1)

Loading locations...

Similar Trials